Hepatobiliary manifestations in inflammatory bowel disease: A practical approach

doi:10.4254/wjh.v14.i2.319

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 2

This Article

Peer-Review Report of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10379)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

596

WORD

147

HTML

5105

Figures (1-3)

812

Tables (1-2)

617

Sum=7277

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

352

Download

1039

Sum=1391

Publishing Process of This Article

Item

Count

Browse

500

Download

1214

Sum=1714

Feb 27, 2022 (publication date) through Mar 5, 2026

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Review

World J Hepatol. Feb 27, 2022; 14(2): 319-337
Published online Feb 27, 2022. doi: 10.4254/wjh.v14.i2.319

Hepatobiliary manifestations in inflammatory bowel disease: A practical approach

Lorena Castro, Diego Diaz, Rodrigo Quera, Gabriel Mezzano, Fabiola Castro, Paulina Núñez F

Paulina Núñez F, Rodrigo Quera, Universidad de los Andes,Inflammatory Bowel Disease Program, Digestive Disease Center, Santiago 7600976, RM, Chile

Paulina Núñez F, Inflammatory Bowel Disease Program, Hospital San Juan de Dios, Universidad de Chile, Santiago 7701230, RM, Chile

Fabiola Castro, Gabriel Mezzano, Lorena Castro, Universidad de los Andes,Hepatology Program, Digestive Disease Center, Santiago 7600976, RM, Chile

Gabriel Mezzano, Department of Gastroenterology, Hospital del Salvador/Universidad de Chile, Santiago 7600976, RM, Chile

Diego Diaz, Medicine, Universidad de los Andes, Santiago 770976, RM, Chile

Author contributions: All authors equally contributed to this review with the conception and design of the study, literature review and analysis, drafting and critical revision and editing, and approval of the final version.

Conflict-of-interest statement: Quera R and Nuñez FP, have received fees for serving as a speaker for Janssen, Castro F, Mezzano G, Diaz D and Castro L had no conflict of interest.

Corresponding author: Paulina Núñez F, MD, Adjunct Professor, Universidad de los Andes, Inflammatory Bowel Disease Program, Digestive disease center, Avda Plaza 2501, Santiago 7600976, RM, Chile. paulinanunez@gmail.com

Received: June 18, 2021
Peer-review started: June 18, 2021
First decision: August 18, 2021
Revised: September 10, 2021
Accepted: January 27, 2022
Article in press: January 27, 2022
Published online: February 27, 2022
Processing time: 249 Days and 6.9 Hours

Core Tip

Core Tip: Inflammatory bowel diseases are associated with various hepatobiliary disorders. They can occur at any moment in the course of the disease or associated with the treatment. Although hepatic manifestations are known, they are not always searched for in a directed manner. This review article presents the main hepatobiliary manifestations, including those caused by new therapies (biologics and small molecules). Finally, we propose a management algorithm.